Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PLCL2 |
| Upstream (Parents) |
|---|
| (<<) PGCP → PLCL2 |
| (<<) GABARAPL3///GABARAPL1 → PLCL2 |
| (<<) CTSO → PLCL2 |
| (<<) DPYD → PLCL2 |
| (<<) CD1D → PLCL2 |
| Downstream (Children) |
|---|
| PLCL2 → TSPAN7 (>>) |
| PLCL2 → SNX24 (>>) |
| PLCL2 → FAS (>>) |
| PLCL2 → TOX3 (>>) |
| PLCL2 → ASAP3 (>>) |
| PLCL2 → CEACAM3 (>>) |
| PLCL2 → C14orf132 (>>) |
| PLCL2 → CADPS2 (>>) |
| PLCL2 → CCDC69 (>>) |
| PLCL2 → DDX27 (>>) |
| PLCL2 → PLCG2 (>>) |
| PLCL2 → HMGB3 (>>) |
| PLCL2 → CBFA2T3 (>>) |
| PLCL2 → CYP26A1 (>>) |
| PLCL2 → PLIN1 (>>) |
| PLCL2 → DPT (>>) |
| PLCL2 → KCNMA1 (>>) |
| PLCL2 → CNTLN (>>) |
| PLCL2 → IL18R1 (>>) |
| PLCL2 → ADRB2 (>>) |
| PLCL2 → KLRD1 (>>) |
| PLCL2 → AASS (>>) |
| PLCL2 → FES (>>) |
| PLCL2 → ALPPL2 (>>) |
| PLCL2 → SLC16A7 (>>) |
| PLCL2 → MATN2 (>>) |
| PLCL2 → CX3CR1 (>>) |
| PLCL2 → MAN1A2 (>>) |
| PLCL2 → LOC729162///LOC389906///LOC286434 (>>) |
| PLCL2 → MAMLD1 (>>) |
